| Immunosuppression for hyperinflammation in COVID-19: a double-edged sword AI Ritchie, A Singanayagam Lancet 395 (10230), 1111, 2020 | 313 | 2020 |
| Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations AI Ritchie, JA Wedzicha Clinics in chest medicine 41 (3), 421-438, 2020 | 258 | 2020 |
| The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma R Hewitt, H Farne, A Ritchie, E Luke, SL Johnston, P Mallia Therapeutic advances in respiratory disease 10 (2), 158-174, 2016 | 191 | 2016 |
| Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK A Abbara, S Chitty, JK Roe, R Ghani, SM Collin, A Ritchie, OM Kon, ... BMC Infectious Diseases 17, 1-9, 2017 | 134 | 2017 |
| Pathogenesis of viral infection in exacerbations of airway disease AI Ritchie, HA Farne, A Singanayagam, DJ Jackson, P Mallia, ... Annals of the American Thoracic Society 12 (Supplement 2), S115-S132, 2015 | 106 | 2015 |
| Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae LJ Finney, A Ritchie, E Pollard, SL Johnston, P Mallia International journal of chronic obstructive pulmonary disease, 1119-1132, 2014 | 102 | 2014 |
| Airway epithelial orchestration of innate immune function in response to virus infection. A focus on asthma AI Ritchie, DJ Jackson, MR Edwards, SL Johnston Annals of the American Thoracic Society 13 (Supplement 1), S55-S63, 2016 | 66 | 2016 |
| Role of microbiome in the pathophysiology and disease course of asthma A Singanayagam, AI Ritchie, SL Johnston Current Opinion in Pulmonary Medicine 23 (1), 41-47, 2017 | 40 | 2017 |
| Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care PL Shah, CM Orton, B Grinsztejn, GC Donaldson, BC Ramírez, J Tonkin, ... The Lancet Respiratory Medicine 11 (5), 415-424, 2023 | 28 | 2023 |
| Repurposing existing drugs for the treatment of COVID-19 H Farne, K Kumar, AI Ritchie, LJ Finney, SL Johnston, A Singanayagam Annals of the American Thoracic Society 17 (10), 1186-1194, 2020 | 24 | 2020 |
| Pleural epithelioid hemangioendothelioma: literature summary and novel case report J Salijevska, R Watson, A Clifford, AI Ritchie, F Mauri, D Adeboyeku Journal of Clinical Medicine Research 7 (7), 566, 2015 | 23 | 2015 |
| β2-Agonists Enhance Asthma-Relevant Inflammatory Mediators in Human Airway Epithelial Cells AI Ritchie, A Singanayagam, E Wiater, MR Edwards, M Montminy, ... American Journal of Respiratory Cell and Molecular Biology 58 (1), 128-132, 2018 | 20 | 2018 |
| Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study TM Rawson, A Abbara, K Kranzer, A Ritchie, J Milburn, T Brown, ... Respiratory Medicine 120, 101-108, 2016 | 20 | 2016 |
| Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study TM Kole, EV Berghe, M Kraft, JM Vonk, MC Nawijn, S Siddiqui, K Sun, ... The Lancet Respiratory Medicine 11 (1), 55-64, 2023 | 18 | 2023 |
| Virus-induced volatile organic compounds are detectable in exhaled breath during pulmonary infection F Kamal, S Kumar, MR Edwards, K Veselkov, I Belluomo, T Kebadze, ... American Journal of Respiratory and Critical Care Medicine 204 (9), 1075-1085, 2021 | 17 | 2021 |
| Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis A Singanayagam, K Manalan, DW Connell, JD Chalmers, S Sridhar, ... The International Journal of Tuberculosis and Lung Disease 20 (12), 1653-1660, 2016 | 17 | 2016 |
| The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. 2016; 10 (2): 158–74 R Hewitt, H Farne, A Ritchie, E Luke, SL Johnston, P Mallia Thorax 69 (3), 247-53, 2014 | 10 | 2014 |
| Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin. A double-blind, randomized, placebo-controlled … AI Ritchie, SE Brill, BH Vlies, LJ Finney, JP Allinson, L Alves-Moreira, ... American journal of respiratory and critical care medicine 202 (4), 549-557, 2020 | 8 | 2020 |
| Clinical and survival differences during separate COVID-19 surges: Investigating the impact of the Sars-CoV-2 alpha variant in critical care patients AI Ritchie, O Kadwani, D Saleh, B Baharlo, LR Broomhead, P Randell, ... PLoS One 17 (7), e0269244, 2022 | 5 | 2022 |
| Metagenomic characterization of the respiratory microbiome. A piece de resistance AI Ritchie, A Singanayagam American Journal of Respiratory and Critical Care Medicine 202 (3), 321-322, 2020 | 5 | 2020 |
